NAION is the second most frequent cause of vision loss due to optic nerve damage, with advanced age and long-standing type 2 ...

Use of GLP-1s, especially semaglutide and liraglutide, may increase risk for nonarteritic anterior ischemic optic neuropathy ...

Liraglutide injection single-patient-use prefilled pens and glucagon for injection vials will be manufactured at Lupin’s ...

A diabetes medication may offer relief for people suffering from chronic migraines. In a new study, researchers found that ...

Brazilian pharmaceutical company EMS announced the release of Olire and Lirux injector pens for obesity and type 2 diabetes, ...

A recent study shows the use of GLP-1 drugs can increase the risk for optic nerve damage in the first year of treatment, ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

SAO PAULO (Reuters) -Brazilian pharmaceutical company EMS on Friday said that local pharmacies will start selling its injector pens aimed at treating diabetes and obesity from August 4. The pens, made ...

For liraglutide specifically, which is currently sold in genericized versions due to patent expiration, Lexaria is now searching for a pharmaceutical partner interested in utilizing DehydraTECH to ...

Semaglutide vs. liraglutide: One-year weight loss efficacy in obesity and type 2 diabetes Download PDF Copy By Dr. Priyom Bose, Ph.D. Reviewed by Benedette Cuffari, M.Sc. Sep 17 2024 ...

Liraglutide was approved by the US Food and Drug Administration in 2014 to help adults lose weight. In 2020, that approval was extended to children ages 12 to 17. The study was published Tuesday ...